April 14, 2021 4:00 a.m.

On Tuesday, staff with the Oregon Health Authority asked all of the state’s vaccine providers to immediately pause administering the Johnson & Johnson vaccine, following an announcement from the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration.

A release said the recommendation for a pause was made out of an abundance of caution as teams from the federal agencies review six reported cases of a rare and severe blood clot in individuals after vaccination with the Johnson & Johnson vaccine.

The measures followed the cases in women ages 18 to 48 with about 6.8 million doses of that vaccine administered nationally to date. Symptoms in these patients began 6 to 13 days following vaccination. OHA said none of the reported cases were in Oregon.

The CDC is convening an advisory committee to review data regarding the situation. OHA said the pause in vaccination is recommended until the reviews are complete.

People who have received the Johnson & Johnson vaccine and develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their health care provider.

As of Monday, 85,148 Johnson & Johnson vaccine doses have been administered in Oregon. 213,300 doses of that vaccine have been delivered to vaccine sites statewide